Tolerability of the niraparib individualized starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy

  1. Vulsteke, C.
  2. Chambers, S.K.
  3. Pérez, M.J.R.
  4. Chan, J.K.
  5. Raaschou-Jensen, N.
  6. Zhuo, Y.
  7. Lorusso, D.
  8. Herzog, T.J.
  9. de la Motte Rouge, T.
  10. Thomes Pepin, J.A.
  11. Braicu, E.I.
  12. Chen, L.-M.
  13. Levy, T.
  14. Barter, J.F.
  15. Pilar Barretina-Ginesta, M.
  16. Joosens, E.
  17. York, W.
  18. Malinowska, I.A.
  19. González-Martín, A.
  20. Monk, B.J.
Aldizkaria:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Argitalpen urtea: 2024

Alea: 208

Mota: Artikulua

DOI: 10.1016/J.EJCA.2024.114157 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus